Deltex Medical Group plc Completion of Placing and Directors shareholdings 23 January 2013 Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that the 13,157,895 new ordinary shares issued as part of the Placing announced on 18 January 2013 have now been admitted for trading.

As part of the arrangements for the Placing, three Non-executive Directors subscribed for approximately £225,000 in the Placing, representing 9% of the issue. These Directors' beneficial interests are now as follows:

Name of Director Number of New Ordinary Shares subscribed as part of Placing Holding of shares following issue of New Ordinary Shares % of enlarged issued share capital

Nigel Keen 789,000 6,687,547 4.1
Sir Duncan Nichol 131,500 853,916 0.5
Julian Cazalet 263,000 3,880,882 2.4
The Company has 164,190,150 ordinary shares in issue. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in Deltex Medical Group plc, under the Disclosure and Transparency Rules.
For further information, please contact:-

Deltex Medical Group plc 01243 774 837

Nigel Keen, Chairman
Ewan Phillips, Chief Executive
Paul Mitchell, Finance Director

Nominated Adviser and Broker 0207 614 5917 Arden Partners plc

Christopher Hardie

distributed by